AWARD
A -- Development Of a Concentrated Tranexamic Acid (TXA) Intramuscular Injection
- Notice Date
- 10/1/2025 9:30:08 AM
- Notice Type
- Award Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- 75A50125C00018
- Archive Date
- 10/15/2025
- Point of Contact
- Erin Greninger, Contracting Officer
- E-Mail Address
-
erin.greninger@hhs.gov
(erin.greninger@hhs.gov)
- Award Number
- 75A50125C00018
- Award Date
- 09/30/2025
- Awardee
- RAFA LABORATORIES LTD Jerusalem ISR
- Award Amount
- 186004780.00
- Description
- This award is for the development of a concentrated Tranexamic Acid (TXA) Intramuscular Injection. The Government seeks this development in order to receive FDA approval for the concentrated IM TXA formulation that can be delivered in a pref-filled syringe or a dedicated autoinjector. This contract action was awarded competitively as a Cost Share Contract. A Cost Share Contract was used in accordance with FAR 35.006 (c) due to an absence of precise specifications and difficulties in estimating costs with accuracy.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/4019083ffaab4e8da012f8752b7ebcee/view)
- Place of Performance
- Address: Jerusalem, IL-JM, ISR
- Country: ISR
- Country: ISR
- Record
- SN07609063-F 20251003/251001230036 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |